The effect of pretreatment BMI on the prognosis and serum immune cells in advanced LSCC patients who received ICI therapy

This study aims to evaluate the prognosis and serum immune cells of patients with different pretreatment body mass index (BMI) values. The data of 61 newly diagnosed patients with advanced lung squamous cell carcinoma (LSCC) who received immune checkpoint inhibitors (ICIs) combined with chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fei, Zhou, Lei, Chen, Na, Li, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909129/
https://www.ncbi.nlm.nih.gov/pubmed/33663076
http://dx.doi.org/10.1097/MD.0000000000024664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909129/
https://www.ncbi.nlm.nih.gov/pubmed/33663076
http://dx.doi.org/10.1097/MD.0000000000024664

Ejemplares similares